Anika Therapeutics vs Outset Medical
Anika Therapeutics and Outset Medical are similar in size: $113m and $119m of revenue in their latest fiscal years. Outset Medical grew faster (5.1% against -5.9%). Anika Therapeutics kept more of each dollar of sales as profit: a net margin of -9.6% against -68.3%. Anika Therapeutics carries less debt relative to equity (0.0% against 75.8%).
| Latest fiscal year | Anika TherapeuticsANIK, 2025 | Outset MedicalOM, 2025 |
|---|---|---|
| Revenue | $113m | $119m |
| Revenue growth | -5.9% | 5.1% |
| Net income | −$10.9m | −$81.7m |
| Operating margin | -9.8% | -55.8% |
| Net margin | -9.6% | -68.3% |
| Return on equity | -7.3% | -106.2% |
| Free cash flow | $4.4m | −$47.1m |
| Cash | $57.5m | $35.0m |
| Total debt | $0 | $96.2m |
| Debt to equity | 0.0% | 75.8% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $9.5m | — |
| Employees | 235 | 254 |
| Market value | $261m | $76.3m |
| Price vs our value range | — | — |
| Moat score | 53 (Moderate) | 12 (Weak) |
| Insider trades, 12 months | 4 buys, 0 sales | 2 buys, 23 sales |